Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,700 public trials 1,041 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

NCT02111681

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

NCT04681131

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • City of Hope - Duarte Duarte, California, United States
  • University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • California Research Institute Los Angeles, California, United States
  • USC Norris Los Angeles, California, United States
View all 60 locations
View Trial Details
Completed

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT03184571

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +14 more
Locations
  • Dartmouth-Hitchcock Medical Center (DHMC) Lebanon, New Hampshire, United States
  • Medical College of Wisconsin, 9200 W Wisconsin Avenue Milwaukee, Wisconsin, United States
  • Radiumhospitalet, Oslo University Hospital PB Oslo, Norway
  • Hospital Universitari Germans Trias i Pujol-ICO Barcelona, Badalona, Spain
View all 13 locations
View Trial Details
Completed

Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer

NCT05014815

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Rj Zuckerberg Cancer Center New Hyde Park, New York, United States
View all 64 locations
View Trial Details
Completed

Special Drug Use-results Surveillance of Tabrecta Tablets

NCT04575025

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Kōnan, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
View all 78 locations
View Trial Details
Completed

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

NCT04344795

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +41 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Baystate Gynecologic Oncology Springfield, Massachusetts, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions